Ribecca A national phase IIIb, multi-center, open label study for women with hormone-receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole
Projektleiter:
Finanzierung:
Industrie;
Ribecca
A national phase IIIb, multi-center, open label study for women with hormone-receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole
A national phase IIIb, multi-center, open label study for women with hormone-receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole
Schlagworte
Hormone
Kontakt
Prof. Dr. habil. Christoph Thomssen
Martin-Luther-Universität Halle-Wittenberg
Universitätsklinik und Poliklinik für Gynäkologie
Ernst-Grube-Str. 40
06120
Halle (Saale)
Tel.:+49 345 5571847
weitere Projekte
Die Daten werden geladen ...